Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Ceragon Networks ( (CRNT) ).
On October 27, 2025, Ceragon Networks announced its participation in several investor conferences scheduled for November 2025, including the Craig-Hallum Alpha Select Conference, ROTH Technology Conference, and Needham Tech Week. This engagement with the investment community highlights Ceragon’s proactive approach to strengthening its market presence and fostering investor relations, potentially impacting its strategic positioning and stakeholder confidence.
The most recent analyst rating on (CRNT) stock is a Buy with a $2.50 price target. To see the full list of analyst forecasts on Ceragon Networks stock, see the CRNT Stock Forecast page.
Spark’s Take on CRNT Stock
According to Spark, TipRanks’ AI Analyst, CRNT is a Outperform.
Ceragon Networks’ overall stock score reflects a balanced view of its financial stability and operational efficiency against challenges in revenue growth and profitability. Technical indicators support a slightly positive outlook, while valuation remains fair. The earnings call underscores resilience in North America but highlights significant revenue challenges in India.
To see Spark’s full report on CRNT stock, click here.
More about Ceragon Networks
Ceragon Networks Ltd. is a global leader in providing end-to-end wireless connectivity solutions, specializing in transport, access, and AI-powered managed and professional services. The company serves a diverse clientele, including service providers, utilities, public safety organizations, government agencies, and energy companies, delivering high-capacity wireless solutions for 5G and 4G broadband connectivity across more than 130 countries.
Average Trading Volume: 759,653
Technical Sentiment Signal: Hold
Current Market Cap: $225.7M
See more data about CRNT stock on TipRanks’ Stock Analysis page.

